Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, Ayurvedic treatment including Pracchan karma, Siro lepa, and Samana chikista over four months resolved symptoms of Alopecia Areata in a woman who maintained improvement one year post-treatment.

This case report describes an 18-year-old female with alopecia areata who experienced hair regrowth within seven days following Prachana Vidhi treatment in an Ayurvedic setting, suggesting this approach may offer effective results for patchy hair loss.

This case study demonstrated the successful use of Ayurvedic detoxification therapies and treatments in a 28-year-old female, leading to significant hair regrowth and reduced hair loss, offering a potential holistic approach for managing Alopecia Areata.

This article explores Ayurvedic approaches to treating hair disorders and provides no new clinical results, highlighting practices like using herbal treatments for hair loss and greying.

This research found that immobilizing type I atelocollagen onto artificial hair significantly improved the adhesion and long-term fixation of the hairs in the human scalp, indicating high biosafety and enhanced tissue integration.

Botulinum toxins show promise in treating various conditions, but more research is needed for hair and scalp disorders.

This study found that in mice with alopecia areata, a single subcutaneous injection of botulinum neurotoxin serotype A significantly reduced hair loss and stimulated hair follicle regeneration.

This study found that vitamin D regulates cholesterol metabolism and may influence prostate cancer development through mechanisms affecting prostate cell growth and sex hormone metabolism.

This paper reviews the Ayurvedic formulation Nilibhringadi Taila, which is claimed to improve hair quality and treat issues such as split hairs, premature greying, and baldness, and emphasizes the need for further research on its uses and effectiveness.

This study evaluated the physicochemical properties of Neelibhringadi keratailam and found significant variations in market samples compared to a prepared sample, indicating potential quality control issues.

This study found that subcutaneous administration of Botulinum toxin type A significantly reduced histamine-induced itch intensity and neurogenic inflammation in human skin compared to saline.

This study found that Botox® was most effective at a 25 U/ml concentration, while Dysport® and Neurobloc® were optimal at 100 U/ml for producing anhidrotic areas after injections.

This study suggests that Botox injections may increase hair count and reduce hair loss in men with androgenetic alopecia, potentially through increased blood flow and oxygen to the scalp.

This review discusses various types of microneedles and their potential to expand the range of drugs delivered via the skin, but reports no new clinical results.

This study found that BOTOX doses of 75–100 U effectively reduce postvoiding residual urine and detrusor pressure in patients with detrusor sphincter dyssynergia.

In this case, ayurvedic medicines were reported to effectively manage a patient with alopecia areata, with fewer side effects and reduced relapse rates compared to conventional treatments.

This review discusses autoimmune blistering diseases across species and highlights new treatment efficacy findings and ongoing trials, but it reports no new clinical results.

This study highlights the roles of dietary nutrients in maintaining skin health, noting that shortages can lead to hard-to-detect dysfunctions, and suggests that nutraceuticals may help address these nutritional gaps and improve skin-related issues linked to aging and dermatoses.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

This study observed that a cream containing functional compounds from medicinal plants increased collagen production in human skin, while a hair tonic enhanced hair growth in mice.

In this study, the novel 5% minoxidil formulation significantly increased scalp hydration and decreased redness in Indian men with androgenetic alopecia compared to alcohol-based formulations.

This study found that self-noncoding dsRNA activates TLR3 to stimulate intrinsic retinoic acid synthesis, promoting new hair follicle formation in wounded mice and showing similar gene expression changes in humans treated with rejuvenation lasers.

This study explored the use of Kasisadi Lepa, a classical herbo-mineral formulation, and found its components could reduce dandruff by addressing scalp inflammation, microbial growth, and tissue damage with potential integration into long-term scalp health strategies.

This study reviewed the pharmacological properties of Priyaladi lepa, an Ayurvedic formulation, and reported its potential anti-dandruff benefits due to anti-inflammatory, anti-fungal, anti-microbial, anti-pruritic, antioxidant, and exfoliation effects, warranting further research for managing Darunaka (dandruff).

This review discusses the efficacy of the lipidosterolic extract of Serenoa repens for treating lower urinary tract symptoms and reports no new clinical results; the authors propose further examination of the existing literature and guidelines.

This review concludes that global literature supports the lipidosterolic extract of Serenoa repens as efficacious and safe for treating lower urinary tract symptoms, with some studies showing equivalence to common pharmacologic agents.

In this clinical trial, the authors observed that Dravanti beeja lepa may be safe and effective for promoting hair regrowth in patients with Indralupta (Alopecia Areata).

In this study, the combination of Serenoa repens extract with Phenolmicin P3 and Bosexil suppositories significantly improved lower urinary tract symptoms and decreased PSA levels in patients with benign prostatic obstruction-related symptoms.

This study found that Lepidium sativum seed extract showed potential in treating alopecia in rats by reducing 5(alpha)-dihydrotestosterone levels and improving hair length compared to minoxidil.

This review concludes that the global literature supports the efficacy and safety of lipidosterolic extract of Serenoa repens in treating lower urinary tract symptoms, comparable to alpha-blockers and 5α-reductase inhibitors.